Glycan Composition Modulating Gut Microbial Processing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a continued need for novel therapies and treatment regimens to effectively address health challenges, as existing methods for modulating immune responses and enhancing drug efficacy are limited.
Innovation Solution
A glycan composition is administered to humans, comprising specific glycan polymers that modulate the activity of drugs like 4-aminosalicylic acid, 5-aminosalicylic acid, balsalazide, olsalazine, or sulfasalazine, by altering microbial processing in the gut, thereby increasing drug activity and therapeutic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional drugs are administered alone, then the treatment regimen is simple, but the drug activity and therapeutic effect are limited
Solution Approach 1:
The patent introduces a glycan composition as an intermediary substance that mediates between the conventional drug and the microbial processing system. The glycan composition modifies microbial processing to enhance drug activity, allowing the drug to work more effectively without requiring a completely new treatment approach. This resolves the contradiction by adding a mediator that boosts therapeutic effect while maintaining relative simplicity of the regimen.
Solution Approach 2:
The patent changes the parameter of drug activity by co-administering glycan composition, which modifies microbial processing parameters. This allows the same drug to produce enhanced therapeutic effects through altered microbial metabolism, resolving the limitation of conventional single-drug regimens without requiring complete regimen redesign.
2Reliability
If glycan composition is administered to increase drug activity, then therapeutic effect is enhanced, but the treatment protocol becomes more complex
Solution Approach 1:
The patent merges the administration of glycan composition with conventional drug therapy into a unified treatment protocol. By combining these substances and their mechanisms of action, the patent creates an integrated approach where the glycan composition works synergistically with the drug, enhancing drug activity while presenting a single combined protocol rather than separate complex interventions.
3Productivity
If microbial processing is altered to increase drug conversion, then active drug forms increase, but control over processing becomes more difficult
Solution Approach 1:
The patent employs the subject's own microbial processing system to convert the drug to active forms, rather than introducing external complex processing machinery. The glycan composition modulates the existing microbial system to enhance conversion efficiency, allowing the body's natural processing mechanisms to serve the therapeutic goal. This resolves the contradiction by utilizing self-service processing that is both efficient and controllable through biological regulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The glycan composition enhances drug activity and therapeutic outcomes by modifying microbial processing, increasing the conversion of prodrugs to active forms and reducing toxic intermediates, thereby improving treatment efficacy and safety.
Implementation Method 1
a glycan composition can alter the way microbes (e.g., gut microbes) mediate the processing of an exogenous substrate in a subject
Data Source
Figure 1A~1C
Figure 2
Figure 3
AI summary
Compositions, e.g., pharmaceutical compositions, nutritional compositions, medical foods, and food ingredients, as well as their methods of use, are provided, for modulating exogenous substances, enzyme activities, and drug activities.